2025-2034 Travel Vaccines Market Outlook: Key Drivers, Emerging Challenges, and Strategic Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Travel Vaccines Industry Market Size Be by 2025?
The market size for travel vaccines has experienced robust growth in the recent past. The market size is projected to increase from $4.73 billion in 2024 and reach $5.14 billion in 2025, advancing at a compound annual growth rate (CAGR) of 8.6%. The factors that contributed to growth in the past include the surge in global travel, government efforts towards travel health, the spread of diseases due to globalization, heightened awareness amongst travelers, and the growth of the travel and tourism sector.

What's the Long-Term Growth Forecast for the Travel Vaccines Market Size Through 2029?
Anticipations are strong for the travel vaccines market size to experience robust expansion in the coming years. Expected to reach $7.49 billion in 2029, its compound annual growth rate (CAGR) is predicted to be 9.9%. Such progress in future era may be credited to factors like an upswing in business travel, looming threats of new infectious diseases, government regulations and prerequisites for entry, ballooning demands for remote holiday destinations, and the cooperative endeavors of governments and pharmaceutical firms. Future trends include personalized vaccine strategies, extension of the market into regions previously unnaffected by endemic diseases, application of digital health technology, regulatory endorsements and simplified approval methods, and revolutionary advancements.

View the full report here:
https://www.thebusinessresearchcompany.com/report/travel-vaccines-global-market-report

What Are the Key Growth Drivers Fueling the Travel Vaccines Market Expansion?
The growth of the travel vaccine market is anticipated to be driven by the expansion of travel and tourism. Travel and tourism encompasses the transit of people or objects, involving modes of transport such as trains, boats, airplanes, and other vehicles across different distant geographical locations. Travel vaccines serve as a vital health protection measure for tourists and travelers when journeying overseas. For example, the United Nations World Tourism Organization (UNWTO), a Spain-based intergovernmental organization promoting tourism, reported in January 2023 that over 900 million tourists went abroad in 2022. This figure not only doubles the previous year's count but also surpasses pre-pandemic figures by 63%. Hence, the surge in travel and tourism fuels the expansion of the travel vaccine market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11918&type=smp

What Are the Key Trends Driving Travel Vaccines Market Growth?
One major trend propelling the travel vaccine market forward is product innovation. Many of the leading companies in the field are creating unique vaccines to maintain their market share. An example of this occurred in August 2022, when Japan's Takeda Pharmaceutical Company Limited obtained approval for QDENGA (Dengue Tetravalent Vaccine) (TAK-003), a vaccine targeted at preventing Dengue fever in individuals aged six to 45. This approval was granted by the Indonesia National Agency for Drug and Food Control. Even for those who've already been exposed to the illness, three years post-immunization, QDENGA demonstrated its ability to consistently offer protection against Datum sickness and the potential for hospitalization.

How Is the Travel Vaccines Market Segmented?
The travel vaccines market covered in this report is segmented -

1) By Disease: Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,
2) By Composition: Mono Vaccines, Combination Vaccines
3) By Booking Channel: Online Booking, In-Person Booking
4) By Application: Domestic Travel, Outbound Travel

Subsegments:
1) By Hepatitis A: Inactivated Hepatitis A Vaccine, Combination Vaccines
2) By Diphtheria, Pertussis, And Tetanus (DPT): DTP Vaccine (Diphtheria, Tetanus, Pertussis), DTaP Vaccine (Diphtheria, Tetanus, And Acellular Pertussis)
3) By Yellow Fever: Live Attenuated Yellow Fever Vaccine, Booster Dosage Vaccines
4) By Typhoid: Inactivated Typhoid Vaccine, Live Attenuated Typhoid Vaccine
5) By Hepatitis B: Recombinant Hepatitis B Vaccine, Combination Vaccines
6) By Measles And Mumps: Measles, Mumps, And Rubella (MMR) Vaccine, Measles And Rubella (MR) Vaccine
7) By Rabies: Rabies Pre-exposure Prophylaxis (PrEP), Rabies Post-exposure Prophylaxis (PEP)
8) By Meningococcal: Meningococcal Conjugate Vaccine, Meningococcal B Vaccine
9) By Other Diseases: Japanese Encephalitis, Cholera, Influenza, Other Emerging Travel Vaccines

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11918&type=smp

Which Companies Are Leading the Charge in Travel Vaccines Market Innovation?
Major companies operating in the travel vaccines market include Pfizer Inc., Johnson and Johnson, Merck & Co. Inc., Sanofi SA, GlaxoSmithKline plc, Biological E. Limited, Takeda Pharmaceutical Company Limited, Novavax Inc., Emergent BioSolutions UK, Serum Institute of India Pvt. Ltd., Dynavax Technologies, Bavarian Nordic A/S, Valneva SE, Panacea Biotec, Vabiotech, Inovio Pharmaceuticals, Bharat Biotech International Limited, Altimmune Inc., Bio Farma, Vaxart Inc.

Which Regions Are Leading the Global Travel Vaccines Market in Revenue?
North America was the largest region in the travel vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the travel vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11918

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.